Enabling Discovery through GEnomics

0
100

Funding Opportunity ID:330430
Opportunity Number:21-546
Opportunity Title:Enabling Discovery through GEnomics
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s):47.074
93.172
Eligible Applicants:Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:*Who May Serve as PI: There are no restrictions or limits.
Agency Code:NSF
Agency Name:National Science Foundation
Posted Date:Dec 17, 2020
Close Date:Mar 16, 2021
Last Updated Date:Dec 17, 2020
Award Ceiling:$2,000,000
Award Floor:$1
Estimated Total Program Funding:$10,000,000
Expected Number of Awards:15
Description:Through the Enabling Discovery through GEnomics (EDGE) program, the National Science Foundation (NSF) and the National Institutes for Health (NIH) support research to advance understanding of comparative and functional genomics. The EDGE program supports the development of innovative tools, technologies, resources, and infrastructure that advance biological research focused on the identification of the causal mechanisms connecting genes and phenotypes. The EDGE program also supports functional genomic research that addresses the mechanistic basis of complex traits in diverse organisms within the context (environmental, developmental, social, and/or genomic) in which they function. These goals are essential to uncovering the rules that underlie genomes-to-phenomes relationships and predict phenotype, an area relevant to Understanding the Rules of Life: Predicting Phenotype, one of the 10 Big Ideas for NSF investment. The goals also support the NHGRI priority to establish the roles and relationships of all genes and regulatory elements in pathways, networks, and phenotypes.
Version:1





Visit the Official Webpage For More Details on Enabling Discovery through GEnomics

LEAVE A REPLY

Please enter your comment!
Please enter your name here